Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3Antonio C. Fuentes-Fayos, Raúl M. Luque|Brain|2020Cited by 103
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidenceAntonio C. Fuentes-Fayos, Raúl M. Luque|EBioMedicine|2023Cited by 45
SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalancesAntonio C. Fuentes-Fayos, Raúl M. Luque|Journal of Experimental & Clinical Cancer Research|2022Cited by 40